Equity · Healthcare
AMGN
NASDAQAmgen (AMGN)
The line runs 378.89 USD on 3 August through 466.11 USD on 30 October, on a scale from 375 to 475. Days the market did not trade hold the previous close, flat.
- Market cap
- 252.0B USD
- P/E (TTM)
- 29.0
- Revenue, year to Dec 2025
- 36.8B USD
- EPS, diluted, year to Dec 2025
- 14.23 USD
- 52-week range
- 291 USD – 467.80 USD
- Avg volume
- 116.1K
- Mentions, 30 days
- 7
- Net sentiment
- +0.25
as of Oct 30, 2026
Have Amgen (AMGN) insiders bought or sold shares recently?
In the 90 days to 1 Nov 2026, Amgen insiders reported 4 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 11 Nov 2025, show no open-market purchase.
Form 4, 90 days to 1 Nov 2026, newest reported trade 13 Aug 2026
Buys 0Sells 4Net sold $4.11MOther filings 7
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 13 Aug 2026 | Khosla RachnaSVP, Business Development | Sell | 1,252 | 521K USD |
| 11 Aug 2026 | Khosla RachnaSVP, Business Development | Sell | 2,000 | 825K USD |
| 06 Aug 2026 | Grygiel Nancy A.SVP & CCO | Sell | 2,970 | 1.2M USD |
| 06 Aug 2026 | Miller DerekSVP, Human Resources | Sell | 3,890 | 1.6M USD |
| Sold | 4 open-market sales | 10,112 | $4.11M |
7 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 13 Aug 2026 | Khosla RachnaSVP, Business Development | Option exercise | 1,252 | 204K USD |
| 07 Aug 2026 | Drake Michael VDirector | Award | 64 | |
| 07 Aug 2026 | HOLLEY CHARLES MDirector | Award | 103 | |
| 07 Aug 2026 | ISHRAK OMARDirector | Award | 85 | |
| 07 Aug 2026 | Busch Matthew C.VP, Finance & CAO | Award | 730 | |
| 06 Aug 2026 | Grygiel Nancy A.SVP & CCO | Option exercise | 2,970 | 527K USD |
| 06 Aug 2026 | Miller DerekSVP, Human Resources | Option exercise | 3,890 | 660K USD |
Which funds hold Amgen (AMGN)?
11 of the 45 institutional funds we track reported a Amgen position for the quarter ended 30 Jun 2026 — a combined 2.0B USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Fisher Asset Management | Held (±25%) | 1,589,554 | 575.6M USD | +0.7% |
| D. E. Shaw & Co. | Added | 1,290,217 | 467.2M USD | +624.8% |
| Two Sigma Investments | Added | 1,128,681 | 408.7M USD | +1,474.6% |
| Citadel Advisors | Added | 703,984 | 254.9M USD | +280.6% |
| AQR Capital Management | Added | 300,007 | 107.8M USD | +97.1% |
| Man Group | Added | 234,023 | 84.7M USD | +64.2% |
| Marshall Wace | Trimmed | 99,402 | 36.0M USD | −68.6% |
| Millennium Management | Trimmed | 79,344 | 28.7M USD | −65.5% |
| Bridgewater Associates | Added | 21,869 | 7.9M USD | +48.0% |
| Balyasny Asset Management | Added | 17,944 | 6.5M USD | +124.9% |
Showing the 10 largest of 11 reported positions. The figures above count all of them.
Have members of Congress traded Amgen (AMGN)?
The most recent congressional trade disclosed in Amgen is a purchase by David J. Taylor (house, OH), dated 22 Sep 2026.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 22 Sep 2026 | David J. Taylorhouse · Republican–OH | Purchase | 1K USD–15K USD | 9 days |
| 26 Aug 2026 | David J. Taylorhouse · Republican–OH | Sale | 1K USD–15K USD | 10 days |
| 05 Jun 2026 | David J. Taylorhouse · Republican–OH | Purchase | 1K USD–15K USD | 7 days |
| 26 Feb 2026 | David J. Taylorhouse · Republican–OH | Sale | 1K USD–15K USD | 8 days |
| 16 Jan 2026 | David J. Taylorhouse · Republican–OH | Purchase | 1K USD–15K USD | 17 days |
| 03 Dec 2025 | David J. Taylorhouse · Republican–OH | Sale | 1K USD–15K USD | 2 days |
| 25 Sep 2025 | Lisa C. McClainhouse · Republican–MI | Sale | 1K USD–15K USD | 27 days |
| 24 Jun 2025 | Lisa C. McClainhouse · Republican–MI | Purchase | 1K USD–15K USD | 50 days |
Amgen (AMGN) US federal contracts
US federal agencies committed 126.0M USD in contracts to Amgen (AMGN) in fiscal 2026, the year to 30 Sep 2026, against 89.9M USD the year before.
USAspending.gov
Fiscal 2026 126.0M USDFiscal 2025 89.9M USDFiscal 2024 129.9M USD
| Signed | Agency | Contract | Committed |
|---|---|---|---|
| 12 Mar 2024 | Office of Assistant Secretary for Preparedness and ResponseDepartment of Health and Human Services | VENDOR MANAGED INVENTORY (VMI) SERVICES FOR USG PROCURED 165,906 DOSES OF NEULASTA PRODUCT TO MITIGATE INJURIES CAUSED BY EXPOSURE TO…HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT · 75A50124C00011 · AMGEN USA INC | 812K USD |
| 28 Sep 2022 | Office of Assistant Secretary for Preparedness and ResponseDepartment of Health and Human Services | TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN.HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT · 75A50122C00065 · AMGEN USA INC | 839.9M USD |
Contracts of US$100,000 or more signed since April 2022; the amount is what the government has committed so far, which grows when options are exercised. Defense Department contracts are published about 90 days after signing, so the latest year is still filling in.
What has been filed or recorded for Amgen (AMGN)?
The filings we hold for Amgen, newest first: 11 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 13 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 447 shares | 187K USD notional · <0.001% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 114 shares | 46K USD notional · <0.001% of shares out |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 1 shares | 413 USD notional · <0.001% of shares out |
| 07 Oct 2026 | Fails to deliver | Shares failed to deliver | 22 shares | 9K USD notional · <0.001% of shares out |
| 06 Oct 2026 | Fails to deliver | Shares failed to deliver | 95 shares | 38K USD notional · <0.001% of shares out |
| 05 Oct 2026 | Fails to deliver | Shares failed to deliver | 70 shares | 28K USD notional · <0.001% of shares out |
| 02 Oct 2026 | Fails to deliver | Shares failed to deliver | 89 shares | 36K USD notional · <0.001% of shares out |
| 30 Sep 2026 | Fails to deliver | Shares failed to deliver | 9,255 shares | 3.9M USD notional · 0.002% of shares out |
| 24 Sep 2026 | Fails to deliver | Shares failed to deliver | 1,948 shares | 791K USD notional · <0.001% of shares out |
| 22 Sep 2026 | Fails to deliver | Shares failed to deliver | 2 shares | 786 USD notional · <0.001% of shares out |
| 21 Sep 2026 | Fails to deliver | Shares failed to deliver | 8,920 shares | 3.4M USD notional · 0.002% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 4.37 USD | |
| 30 Jun 2026 | Financials | Total assets | 95.6B USD | at period end |
| 30 Jun 2026 | Financials | Total equity | 11.7B USD | at period end |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 3.34 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 14.23 USD | |
| 31 Dec 2025 | Financials | Revenue | 36.8B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 7.7B USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 14.23 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 5.93 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 2.65 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 3.20 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 7.56 USD | |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS 5.22 USD |
What is Reddit saying about Amgen (AMGN)?
Reddit mentioned AMGN 7 times in the 30 days to 1 November 2026, across 3 of the communities we track. All of them were scored for sentiment: 86% read bullish, 14% bearish and 0% neither. Reddit data updated 1 November 2026.
30-day window, Method
Mentions, 30 days 7Bullish 86%Bearish 14%Communities 3Against the market +32 points
How do Reddit mentions of Amgen (AMGN) compare with its price?
Share ↗
Where Amgen (AMGN) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 43% | 3 | +0.01 |
| r/stocks | 43% | 3 | +0.56 |
| r/etfs | 14% | 1 | +0.06 |
Amgen (AMGN): frequently asked questions
What did Amgen shares close at?
Amgen closed at 466.11 USD on 30 Oct 2026, down 0.36% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Amgen’s market cap?
Amgen is worth 252.0B USD by market value as of 30 Oct 2026, which is the share price times the shares on issue from its SEC filings.
What is Amgen’s P/E ratio?
Amgen has a price-to-earnings ratio of 29.0, as of 30 Oct 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Amgen’s revenue?
Amgen reported revenue of 36.8B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Amgen insiders bought or sold shares recently?
In the 90 days to 1 Nov 2026, Amgen insiders reported 4 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 11 Nov 2025, show no open-market purchase. A further 7 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Amgen?
11 of the 45 funds we track reported a Amgen position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Fisher Asset Management, D. E. Shaw & Co. and Two Sigma Investments. See Funds
Have members of Congress traded Amgen?
Yes. 36 trades in Amgen appear in the congressional disclosures we hold; the latest is a purchase by David J. Taylor (House, OH) dated 22 Sep 2026, filed 1 Oct 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Amgen last report earnings?
Amgen last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of 4.37 USD; no next date is announced in SEC filings yet. See Filings
Does Amgen have government contracts?
Yes. US federal agencies committed 126.0M USD in contracts to it in fiscal 2026, the year to 30 Sep 2026 (USAspending.gov). See Contracts
What is Reddit saying about Amgen?
Amgen was mentioned 2 times in the last 7 days across the finance subreddits we track, and 7 times over the trailing 30 days. Of the 7 mentions scored for sentiment, 86% read bullish and 14% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- USAspendingUSAspending.gov (U.S. Department of the Treasury), federal prime contract awards
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings
- Wikipediatext of the lead paragraph, licensed CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) — https://en.wikipedia.org/wiki/Amgen